189 related articles for article (PubMed ID: 18498117)
1. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
[TBL] [Abstract][Full Text] [Related]
2. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
3. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
5. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
[TBL] [Abstract][Full Text] [Related]
6. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
7. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
[TBL] [Abstract][Full Text] [Related]
8. The Role of
Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
[No Abstract] [Full Text] [Related]
9. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
[TBL] [Abstract][Full Text] [Related]
10. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
11. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
van Baars R; van der Marel J; Snijders PJ; Rodriquez-Manfredi A; ter Harmsel B; van den Munckhof HA; Ordi J; del Pino M; van de Sandt MM; Wentzensen N; Meijer CJ; Quint WG
Int J Cancer; 2016 Jan; 138(2):463-71. PubMed ID: 26219541
[TBL] [Abstract][Full Text] [Related]
12. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
[TBL] [Abstract][Full Text] [Related]
13. Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
Mazumder Indra D; Mitra S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Chakravarty R; Panda CK
Hum Genet; 2011 Dec; 130(6):735-48. PubMed ID: 21643982
[TBL] [Abstract][Full Text] [Related]
14. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
15. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
[TBL] [Abstract][Full Text] [Related]
16. Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.
Uijterwaal MH; van Zummeren M; Kocken M; Luttmer R; Berkhof J; Witte BI; van Baal WM; Graziosi GCM; Verheijen RHM; Helmerhorst TJM; van Dijken DKE; Spruijt JWM; van Kemenade FJ; Fransen-Daalmeijer N; Bekker-Lettink M; Heideman DAM; Snijders PJF; Steenbergen RDM; Meijer CJLM
Gynecol Oncol; 2016 Oct; 143(1):135-142. PubMed ID: 27430395
[TBL] [Abstract][Full Text] [Related]
17. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
[TBL] [Abstract][Full Text] [Related]
18. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
19. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
[TBL] [Abstract][Full Text] [Related]
20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
